Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vanda Pharmaceuticals (VNDA) Inventory Average (2016 - 2025)

Historic Inventory Average for Vanda Pharmaceuticals (VNDA) over the last 15 years, with Q4 2025 value amounting to $10.5 million.

  • Vanda Pharmaceuticals' Inventory Average rose 1054.01% to $10.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $10.5 million, marking a year-over-year increase of 1054.01%. This contributed to the annual value of $10.3 million for FY2025, which is 413.33% up from last year.
  • Per Vanda Pharmaceuticals' latest filing, its Inventory Average stood at $10.5 million for Q4 2025, which was up 1054.01% from $10.2 million recorded in Q3 2025.
  • Over the past 5 years, Vanda Pharmaceuticals' Inventory Average peaked at $11.3 million during Q4 2022, and registered a low of $6.3 million during Q1 2021.
  • Its 5-year average for Inventory Average is $9.5 million, with a median of $10.0 million in 2024.
  • In the last 5 years, Vanda Pharmaceuticals' Inventory Average surged by 7911.42% in 2021 and then plummeted by 930.94% in 2023.
  • Quarter analysis of 5 years shows Vanda Pharmaceuticals' Inventory Average stood at $8.2 million in 2021, then surged by 37.19% to $11.3 million in 2022, then decreased by 9.31% to $10.2 million in 2023, then dropped by 6.83% to $9.5 million in 2024, then increased by 10.54% to $10.5 million in 2025.
  • Its last three reported values are $10.5 million in Q4 2025, $10.2 million for Q3 2025, and $10.3 million during Q2 2025.